ADMP logo

Adamis Pharmaceuticals (ADMP) Non Current Assets

Annual Non Current Assets

$1.66 M
-$1.44 M-46.40%

December 31, 2022

Summary

Performance

1-Year Change

-46.4%

3-Year Change

-95.12%

5-Year Change

-94.46%

15-Year Change

-94.46%

ADMP Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$33.96 M
ADMP annual long term assets is currently -95.12% below its historical high of $33.96 million

3-Year Low

$1.66 M
ADMP annual long term assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ADMP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ADMP next annual earnings announcement has not yet been scheduled

OtherADMPbalance sheetmetrics:

Annual Total Assets

$10.93 M
ADMP annual total assets is $10.93 million

Annual Current Assets

$9.27 M
ADMP annual total current assets is $9.27 million

Annual Total Liabilities

$11.74 M
ADMP annual total liabilities is $11.74 million

Annual Total Long Term Liabilities

$343.00 K
ADMP annual total long term liabilities is $343.00 thousand

Quarterly Non Current Assets

$1.30 M
-$230.60 K-15.08%

June 30, 2023

Summary

Performance

3-Month Change

-15.08%

1-Year Change

-45.3%

3-Year Change

-95.31%

5-Year Change

-95.77%

ADMP Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$35.17 M
ADMP quarterly long term assets is currently -96.31% below its historical high of $35.17 million

3-Year Low

$1.30 M
ADMP quarterly long term assets is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPbalance sheetmetrics:

Quarterly Total Assets

$4.75 M
ADMP quarterly total assets is $4.75 million

Quarterly Current Assets

$3.45 M
ADMP quarterly total current assets is $3.45 million

Quarterly Total Liabilities

$16.57 M
ADMP quarterly total liabilities is $16.57 million

Quarterly Long Term Liabilities

$1.57 M
ADMP quarterly total long term liabilities is $1.57 million

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

ADMP Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-46.4%-45.3%
3 y3 years-95.1%-95.3%
5 y5 years-94.5%-95.8%

ADMP Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-46.4%at low-58.0%at low
5 y5-year-95.1%at low-96.2%at low
alltimeall time-95.1%-100.0%-96.3%-100.0%

Adamis Pharmaceuticals Non Current Assets History

DateAnnualQuarterly
Jun 2023
-
$1.30 M(-15.1%)
Mar 2023
-
$1.53 M(-7.8%)
Dec 2022
$9.27 M(-73.7%)
$1.66 M(-19.1%)
Sep 2022
-
$2.05 M(-13.7%)
Jun 2022
-
$2.37 M(-13.9%)
Mar 2022
-
$2.76 M(-10.9%)
Dec 2021
$35.20 M(+181.1%)
$3.09 M(-2.6%)
Sep 2021
-
$3.18 M(-81.9%)
Jun 2021
-
$17.58 M(-2.4%)
Mar 2021
-
$18.01 M(-1.8%)
Dec 2020
$12.52 M(-9.7%)
$18.34 M(-31.5%)
Sep 2020
-
$26.77 M(-3.4%)
Jun 2020
-
$27.71 M(-7.5%)
Mar 2020
-
$29.95 M(-11.8%)
Dec 2019
$13.88 M(-46.2%)
$33.96 M(-1.6%)
Sep 2019
-
$34.53 M(-1.7%)
Jun 2019
-
$35.12 M(-0.1%)
Mar 2019
-
$35.17 M(+8.0%)
Dec 2018
$25.78 M(+20.1%)
$32.57 M(+0.1%)
Sep 2018
-
$32.53 M(+6.0%)
Jun 2018
-
$30.69 M(+2.8%)
Mar 2018
-
$29.85 M(-0.3%)
Dec 2017
$21.46 M(+203.5%)
$29.94 M(+0.5%)
Sep 2017
-
$29.78 M(-0.0%)
Jun 2017
-
$29.79 M(-0.7%)
Mar 2017
-
$30.00 M(-2.3%)
Dec 2016
$7.07 M(+70.3%)
$30.72 M(+18.0%)
Sep 2016
-
$26.02 M(-2.9%)
Jun 2016
-
$26.81 M(+249.8%)
Mar 2016
-
$7.66 M(-3.1%)
Dec 2015
$4.15 M(+5.0%)
$7.91 M(-3.5%)
Sep 2015
-
$8.20 M(-2.9%)
Jun 2015
-
$8.45 M(-2.8%)
Mar 2015
-
$8.70 M(-4.6%)
Dec 2014
$3.95 M(-27.0%)
-
Sep 2014
-
$9.11 M(-3.1%)
Jun 2014
-
$9.41 M(-3.1%)
Mar 2014
$5.42 M(+1443.9%)
$9.70 M(-3.0%)
Dec 2013
-
$10.00 M(>+9900.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
$350.90 K(+799.7%)
$0.00(-100.0%)
Dec 2012
-
$130.00 K(0.0%)
Sep 2012
-
$130.00 K(0.0%)
Jun 2012
-
$130.00 K(0.0%)
Mar 2012
$39.00 K(-97.5%)
$130.00 K(0.0%)
Dec 2011
-
$130.00 K(0.0%)
Sep 2011
-
$130.00 K(-35.0%)
Jun 2011
-
$200.00 K(0.0%)
Mar 2011
$1.53 M(+370.1%)
$200.00 K(>+9900.0%)
Dec 2010
-
$1000.00(-67.7%)
Sep 2010
-
$3100.00(-65.2%)
Jun 2010
-
$8900.00(-97.5%)
Mar 2010
$326.20 K
$350.00 K(+1435.1%)
Dec 2009
-
$22.80 K(-16.8%)
Sep 2009
-
$27.40 K(+1.1%)
DateAnnualQuarterly
Jun 2009
-
$27.10 K(>+9900.0%)
Mar 2009
-
$0.00(0.0%)
Dec 2008
$163.40 K(-92.2%)
$0.00(-100.0%)
Sep 2008
-
$532.00 K(+2.5%)
Jun 2008
-
$519.00 K(+2.6%)
Mar 2008
-
$506.00 K(>+9900.0%)
Dec 2007
$2.09 M(-49.5%)
$0.00(0.0%)
Sep 2007
-
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
Mar 2007
-
$0.00(0.0%)
Dec 2006
$4.15 M(-8.4%)
$0.00(0.0%)
Sep 2006
-
$0.00(-100.0%)
Jun 2006
-
$338.00 K(-77.2%)
Mar 2006
-
$1.48 M(-23.0%)
Dec 2005
$4.52 M(-54.2%)
$1.93 M(-23.1%)
Sep 2005
-
$2.50 M(-1.9%)
Jun 2005
-
$2.55 M(-9.0%)
Mar 2005
-
$2.80 M(-29.7%)
Dec 2004
$9.87 M(-16.6%)
$3.99 M(+19.6%)
Sep 2004
-
$3.34 M(+9.6%)
Jun 2004
-
$3.04 M(-9.6%)
Mar 2004
-
$3.37 M(-3.4%)
Dec 2003
$11.85 M(-51.1%)
$3.49 M(-33.1%)
Sep 2003
-
$5.21 M(-60.1%)
Jun 2003
-
$13.04 M(+3.4%)
Mar 2003
-
$12.61 M(+204.5%)
Dec 2002
$24.24 M(+126.8%)
$4.14 M(-4.5%)
Sep 2002
-
$4.33 M(-38.2%)
Jun 2002
-
$7.01 M(-38.9%)
Mar 2002
-
$11.47 M(-1.8%)
Dec 2001
$10.69 M(-34.3%)
$11.68 M(-11.3%)
Sep 2001
-
$13.17 M(+42.8%)
Jun 2001
-
$9.23 M(+93.1%)
Mar 2001
-
$4.78 M(-4.3%)
Dec 2000
$16.26 M(+27.1%)
$4.99 M(+10.7%)
Sep 2000
-
$4.51 M(-21.4%)
Jun 2000
-
$5.74 M(+41.8%)
Mar 2000
-
$4.05 M(-50.1%)
Dec 1999
$12.80 M(+24.3%)
$8.11 M(-37.1%)
Sep 1999
-
$12.90 M(+130.4%)
Jun 1999
-
$5.60 M(-22.2%)
Mar 1999
-
$7.20 M(-21.7%)
Dec 1998
$10.30 M(0.0%)
$9.20 M(+7.0%)
Sep 1998
-
$8.60 M(-17.3%)
Jun 1998
-
$10.40 M(-22.4%)
Mar 1998
-
$13.40 M(+8.1%)
Dec 1997
$10.30 M(+83.9%)
$12.40 M(+313.3%)
Sep 1997
-
$3.00 M(>+9900.0%)
Jun 1997
-
$0.00(-100.0%)
Mar 1997
-
$1.00 M(-52.4%)
Dec 1996
$5.60 M(+40.0%)
$2.10 M(+2000.0%)
Sep 1996
-
$100.00 K(>+9900.0%)
Jun 1996
-
$0.00(-100.0%)
Mar 1996
-
$100.00 K(>+9900.0%)
Dec 1995
$4.00 M
$0.00(0.0%)
Sep 1995
-
$0.00(-100.0%)
Jun 1995
-
$500.00 K

FAQ

  • What is Adamis Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals annual non current assets year-on-year change?
  • What is Adamis Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals quarterly non current assets year-on-year change?

What is Adamis Pharmaceuticals annual long term assets?

The current annual non current assets of ADMP is $1.66 M

What is the all time high annual non current assets for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high annual long term assets is $33.96 M

What is Adamis Pharmaceuticals annual non current assets year-on-year change?

Over the past year, ADMP annual long term assets has changed by -$1.44 M (-46.40%)

What is Adamis Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of ADMP is $1.30 M

What is the all time high quarterly non current assets for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high quarterly long term assets is $35.17 M

What is Adamis Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, ADMP quarterly long term assets has changed by -$1.08 M (-45.30%)